Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Director departure
Credit agrmnt [a]

Gossamer Bio, Inc. (GOSS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 DEL AM Form DEL AM - Delaying amendment:
08/18/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/18/2023 RW Form RW - Registration Withdrawal Request:
08/17/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update - Seralutinib Phase 3 PROSERA Study in PAH Patients Expected to Initiate in 3Q23 -"
08/07/2023 D Form D - Notice of Exempt Offering of Securities:
07/28/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
06/09/2023 4 GALA RENEE D (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
06/09/2023 4 Cox Russell J. (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
06/09/2023 4 Milligan Sandra (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
06/09/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GOSSAMER BIO, INC."
06/09/2023 4 Daniel Thomas O (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
06/09/2023 4 Burow Kristina (Director) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 35,000 options to buy @ $1.26, valued at $44.1k
05/10/2023 SC 13G/A STATE STREET CORP reports a 1.4% stake in EXIT FILING GOSSAMER BIO INC
05/09/2023 4 Peterson Caryn (EVP, Regulatory Affairs) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Disposed/sold 48,500 options to buy @ $22.1, valued at $1.1M
Disposed/sold 13,750 options to buy @ $16.4, valued at $225.5k
Disposed/sold 34,175 options to buy @ $14.55, valued at $497.2k
Disposed/sold 28,250 options to buy @ $9.79, valued at $276.6k
Disposed/sold 31,750 options to buy @ $8.49, valued at $269.6k
Disposed/sold 190,000 options to buy @ $11.94, valued at $2.3M
Granted 32,334 options to buy @ $0
Granted 9,167 options to buy @ $0
Granted 22,784 options to buy @ $0
Granted 18,834 options to buy @ $0
Granted 21,167 options to buy @ $0
05/09/2023 4 Aranda Richard (Chief Medical Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Disposed/sold 45,000 options to buy @ $22.1, valued at $994.5k
Disposed/sold 13,750 options to buy @ $16.4, valued at $225.5k
Disposed/sold 34,175 options to buy @ $14.55, valued at $497.2k
Disposed/sold 60,000 options to buy @ $9.79, valued at $587.4k
Disposed/sold 30,000 options to buy @ $8.47, valued at $254.1k
Disposed/sold 190,000 options to buy @ $11.94, valued at $2.3M
Granted 30,000 options to buy @ $0
Granted 9,167 options to buy @ $0
Granted 22,784 options to buy @ $0
Granted 40,000 options to buy @ $0
Granted 20,000 options to buy @ $0
05/09/2023 4 Christian Waage (EVP, Tech Ops and Admin) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Disposed/sold 105,000 options to buy @ $22.1, valued at $2.3M
Disposed/sold 71,500 options to buy @ $14.55, valued at $1M
Disposed/sold 90,000 options to buy @ $9.79, valued at $881.1k
Disposed/sold 190,000 options to buy @ $11.94, valued at $2.3M
Granted 70,000 options to buy @ $0
Granted 47,667 options to buy @ $0
Granted 60,000 options to buy @ $0
Granted 126,667 options to buy @ $0
05/09/2023 4 Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Disposed/sold 145,000 options to buy @ $22.1, valued at $3.2M
Disposed/sold 71,500 options to buy @ $14.55, valued at $1M
Disposed/sold 90,000 options to buy @ $9.79, valued at $881.1k
Disposed/sold 150,000 options to buy @ $10.54, valued at $1.6M
Disposed/sold 265,000 options to buy @ $11.94, valued at $3.2M
Granted 96,667 options to buy @ $0
Granted 47,667 options to buy @ $0
Granted 60,000 options to buy @ $0
Granted 100,000 options to buy @ $0
Granted 176,667 options to buy @ $0
05/09/2023 4 Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 750,000 options to buy @ $1.36, valued at $1M
05/09/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/09/2023 8-K Quarterly results
Docs: "Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update - Feedback on Planned Registrational Program for Seralutinib Received from FDA and EMA following Successful Phase 2 TORREY Study -"
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 SC 13G/A BlackRock Inc. reports a 4.9% stake in GOSSAMER BIO, INC.
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/05/2023 4 Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Bought 55,000 shares @ $1.0199, valued at $56.1k
04/03/2023 8-K Other Events  Interactive Data
03/22/2023 4 Carter Laura (Chief Scientific Officer) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 157,500 options to buy @ $1.21, valued at $190.6k
03/22/2023 4 Peterson Caryn (EVP, Regulatory Affairs) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 157,500 options to buy @ $1.21, valued at $190.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy